Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 19, 2021
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
[ Thu, Aug 19th 2021
] - WOPRAI
Wed, August 18, 2021
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
[ Wed, Aug 18th 2021
] - WOPRAI
Matthew Harrison Maintained (ALVR) at Buy with Decreased Target to $47 on, Aug 18th, 2021
Matthew Harrison of Morgan Stanley, Maintained "AlloVir, Inc." (ALVR) at Buy with Decreased Target from $50 to $47 on, Aug 18th, 2021.
Matthew has made no other calls on ALVR in the last 4 months.
There is 1 other peer that has a rating on ALVR. Out of the 1 peers that are also analyzing ALVR, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $42 on, Thursday, May 6th, 2021
